Morgan Stanley initiated coverage of Option Care Health (OPCH) with an Overweight rating and $35 price target The company is well positioned amid rising prevalence of chronic disease and focus on lower-cost care centers, the analyst tells investors in a research note. The firm says Option Care is a leader in the home and alternative-site infusion market, offering a critical solution to the healthcare system.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health: Positioned for Growth in the Expanding Infusion Market
- These 3 “Strong Buy” Value Stocks Have over 20% Upside, According to Analysts – 10/14/2025
- Option Care Health: Strong Market Position and Financials Balanced by Lack of Near-Term Catalysts
- Option Care Health initiated with a Hold at TD Cowen
- Option Care Health Amends Credit Agreement for Refinancing